Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
9.54M
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
75.5K
-
Shares change
-
+21.1K
-
Total reported value, excl. options
-
$201K
-
Value change
-
+$24.7K
-
Number of buys
-
5
-
Number of sells
-
-2
-
Price
-
$2.67
Significant Holders of Neuraxis, INC - Common Stock, $0.001 par value per share (NRXS) as of Q4 2023
9 filings reported holding NRXS - Neuraxis, INC - Common Stock, $0.001 par value per share as of Q4 2023.
Neuraxis, INC - Common Stock, $0.001 par value per share (NRXS) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 75.5K shares
of 9.54M outstanding shares and own 0.79% of the company stock.
Largest 9 shareholders include STIFEL FINANCIAL CORP (25.7K shares), VANGUARD GROUP INC (17.7K shares), ROYAL BANK OF CANADA (15.1K shares), PARSONS CAPITAL MANAGEMENT INC/RI (13K shares), Tower Research Capital LLC (TRC) (3.98K shares), WELLS FARGO & COMPANY/MN (8 shares), JPMORGAN CHASE & CO (2 shares), UBS Group AG (0 shares), and Bank of New York Mellon Corp (0 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.